-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

701. Experimental Transplantation: Basic and Translational: Poster II

Symposia: Experimental Transplantation: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Motoko Koyama, MD, PhD1, Luke Samson1*, Kathleen S Ensbey2*, Andrew D Clouston, MD3*, Paul J Martin, MD4,5 and Geoffrey R Hill, MD2,6

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
3Envoi Specialist Pathologists, Brisbane, Australia
4Clinical Research Division, Fred Hutchinson Cancer Research Center, SEATTLE, WA
5Division of Medical Oncology, University of Washington School of Medicine, Seattle, WA
6Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA

James L.M. Ferrara, MD, DSc1, Mariano Prado Acosta, PhD2*, Seihwan Jeong3*, John E. Levine, MD, MS4, Ernst Holler, MD, PhD5*, Joshua Webster6*, George Morales7* and Domagoj Vucic8*

1Tisch Cancer Institute, Icahn School of Medicine, New York, NY
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
3Tisch Cancer Center, Mount Sinai, New York, NY
4Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, NY
5Klinikum der Universitat Regensburg, Regensburg, DEU
6Department of Pathology, Genentech, San Francisco, CA
7Tisch Cancer Institute, Icahn School of Medicine At Mount Sinai, New York, NY
8Department of Early Discovery Biochemistry, Genentech, San Francisco, CA

Masahiro Miyata1*, Eri Matsuki, MD1*, Yuka Hosokawa, MD2*, Masahiro Suto, PhD3*, Kazunobu Ichikawa, MD, PhD1*, Dan Peltier4, Kenichi Ishizawa, MD, PhD2*, Masafumi Watanabe, MD, PhD1* and Tomomi Toubai, MD, PhD2

1Department of Cardiology, Pulmonology, and Nephrology, Yamagata University, Yamagata, Japan
2Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University, Yamagata, Japan
3Pharmaceutical and Medical Device Regulatory Science, Yamagata University Hospital, Yamagata, YAM, Japan
4Division of Pediatric Hematology/Oncology, University of Michigan Medical School, Ann Arbor, MI

Leolene Carrington, PhD1*, Shovik Bandyopadhyay, MSTP Candidate2,3*, Katlyn Lederer4*, Samantha Kelly, MS4*, Ashley Vanderbeck5*, Gloria Jih, PhD6*, Frederick Allen, PhD7*, Daniela Gómez Atria, PhD6*, Anneka Allman, BA8*, Eric Perkey, BS9*, Kai Tan, PhD10,11, Norbert Pardi, PhD4*, Burkhard Ludewig, PhD12*, Ronjon Chakraverty, BMBS, PhD13* and Ivan Maillard, MD, PhD14

1University of Pennsylvania, Philadelphia, PA
2Graduate Group in Cell & Molecular Biology, University of Pennsylvania, Philadelphia, PA
3Medical Scientist Training Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4The University of Pennsylvania Perelman School of Medicine, Philadelphia
5University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA
6The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
7Perelman School of Medicine, Philadelphia, PA
8Department of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA
9University of Michigan, Ann Arbor, MI
10Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA
11Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA
12Institute of Immunobiology, Kantonsspital St. Gallen, St Gallen, Switzerland
13UCL Cancer Institute; Institute of Immunity and Transplantation, London, United Kingdom
14Division of Hematology and Oncology, Abramson Cancer Center University of Pennsylvania, Philadelphia, PA

Sascha Göttert1*, Erik Thiele-Orberg2*, Kaiji Fan1*, Sakhila Ghimire, BSc, MSc, PhD3*, Paul Heinrich1*, Wolfgang Herr, MD4, Simon Heidegger5*, Ernst Holler, MD, PhD6 and Hendrik Poeck, MD7

1University Hospital Regensburg, Regensburg, Germany
2Technical University of Munich (TUM), School of Medicine, Klinikum rechts der Isar, Department for Internal Medicine III, Munich, Germany, Munich, BY, DEU
3University Hospital Regensburg, Regensburg, Bavaria, DEU
4Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
5Department of Medicine III, School of Medicine, Technical University of Munich, Munich, Germany
6Department of Internal Medicine III, Univeristy Hospital Regensburg, Regensburg, Germany
7Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Bavaria, Germany

Byung-Su Kim, MD1, Ji-Young Lim2* and Chang-Ki Min, MD, PhD3*

1Department of Hematology, Eunpyeong St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
2Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Korea, Republic of (South)
3Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

Priscila Ferreira Slepicka, Phd1*, Kelsea M Hubka, PhD2*, Hanh Dan Nguyen2*, Abdulvasey Mohammed2*, Jing Wang, MD3*, Casey Gifford, PhD4*, Vittorio Sebastiano, PhD5* and Katja G. Weinacht, MD, PhD6

1Department of Pediatrics/ Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford School of Medicine, Stanford, CA
2Department of Pediatrics/ Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford School of Medicine, Palo Alto, CA
3Stanford Islet Research Core, Stanford School of Medicine, Stanford, CA
4Department of Pediatrics/ Division of Cardiology, Stanford School of Medicine, Palo Alto, CA
5Stem Cell Institute, Stanford School of Medicine, Stanford, CA
6Stanford University School of Medicine, Stanford, CA

Yan Yi Chan1*, Pui Yan Ho2*, Leah Swartzrock3*, Maire Rayburn2*, Rofida Nofal, MD2*, Supawat Thongthip3*, Kenneth I. Weinberg, MD4 and Agnieszka Czechowicz, MD, PhD5,6,7

1Stanford University, Stanford
2Stanford University School of Medicine, Stanford, CA
3Stanford University, Stanford, CA
4Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
5Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, CA
6Division of Pediatric Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
7Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA

Ezhilarasi Chendamarai, PhD1*, Julie K. Ritchey2*, Leah Gehrs1*, Michael P. Rettig, PhD1, Sai Mukund Ramakrishnan1*, Christopher A Miller, PhD1*, George Cox, Ph.D3*, Lana Anderson3*, Timothy J. Ley, MD1 and John F. DiPersio, MD, PhD2

1Department of Medicine, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
2Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
3Bolder BioTechnology, Boulder, CO

Lara M Breyer1*, Hui Wang, MD, PhD2*, Dongsheng Gu, PhD3*, Brian H Johnstone, PhD4*, Huihui Ma, PhD5*, Erik J Woods, PhD6* and Markus Y. Mapara, MD2,7

1Columbia Center for Translational Immunology, Columbia University Medical Center, New York
2Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY
3Ossium, Indianapolis
4Ossium Health, San Francisco, CA
5Columbia Center for Translational Immunology, Columbia University, New York, NY
6Ossium Health, Indianapolis
7Department of Medicine, Division of Hematology/Oncology, Columbia University College of Physcians and Surgeons, New York, NY

Hua Li1*, Zheyang Zhang2*, Ming Zhu, PhD.2*, Xiaofan Li, MD, PhD3, Tao Chen, MD4*, Yuanzhong Chen, MD, PhD5*, Jialiang Huang, PhD.2* and Nainong Li, MD, PhD5

1Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China
2State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, China
3Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China
4Department of hematology and Cellular-therapy, Xiang’an Hospital, School of Medicine, Xiamen University, Xiamen, China
5Department of Hematology, Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, China

Yongxia Wu1*, Steven Schutt2*, Arjun Kharel3*, Hee-Jin Choi, MD, PhD4*, Weiguo Cui3*, Xian Zhang, PhD5*, Yaacov Ben-David, PhD6* and Xue-Zhong Yu, MD, MSc4

1Medical College of Wisconsin, Milwaukee, WI
2Daniel McVicar Laboratory, National Cancer Institute, Frederick
3Medical College of Wisconsin, Milwaukee
4Microbiology and Immunology, Medical College of Wisconsin, Wauwatosa, WI
5Division of Rheumatology and Immunology, Medical University of South Carolina, Charleston, SC
6Guizhou Medical University, Guiyang, CHN

Gao Mengge1*, Jun Kong2*, Yuqian Sun2*, Zhidong Wang2*, Ting-Ting Han3*, Meng Lyu4*, Yu Wang3*, Xiaosu Zhao5* and Xiao Jun Huang, MD6

1Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China, Beijing, China
2Peking University People’s Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
3Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Beijing, China
4Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of HSCT, Peking University, Beijing, China, Beijing, China
5Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Peking University, Beijing, China
6Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

Jiabao He1*, Ke Zhao2*, Rongtao Xue3*, Hua Jin, PhD1* and Qifa Liu, MD4

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Southern Medical University/Nanfang Hospital/Department of Hematology, Guangzhou, China
3Department of Hematology, Nanfang Hospital, Guangzhou, China
4Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Apeksha Dave1*, Suying Liu2*, John S Riley, MD, MS1, Sourav Bose, MD, MBA, MSc1*, Pallavi Menon1*, Peter Kurre, MD2 and William H Peranteau, MD1*

1Center for Fetal Research, Children's Hospital of Philadelphia, Philadelphia, PA
2Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, PA

Negar Seyedhassantehrani, PhD Candidate1,2*, Christian Burns, PhD Candidate2,3*, Ruth Verrinder2,4* and Joel Spencer, PhD2,5,6*

1Department of Bioengineering, University of California Merced, MERCED, CA
2NSF Crest Center for Biomolecular Machines, University of California Merced, Merded, CA
3Department of Bioengineering, University of California Merced, Merced
4Department of Bioengineering, University of California Merced, Merded, CA
5Department of Bioengineering, University of California Merced, Merced, CA
6Health Science Research Institute, University of California Merced, Merded, CA

Aditya R. Yelamali1*, Stephen P. Persaud, MD, PhD2 and John F. DiPersio, MD, PhD3

1Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
2Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO
3Department of Internal Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Archana Ramgopal, DO1, Lee-Kai Sun, BSc2*, Erica Lynne Braverman, MD3,4, Manda Ramsey, BS5*, Darlene Monlish, Ph.D.5* and Craig Byersdorfer, MD, PhD6

1UPMC, Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
2University of Pittsburgh School of Medicine, Pittsburgh, PA
3Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
4Children's Hospital of Pittsburgh, Pittsburgh, PA
5University of Pittsburgh, Pittsburgh, PA
6Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, University of Pittsburgh, Pittsburgh, PA

Ashley Vanderbeck1*, Samantha Kelly, BS2*, Leolene Carrington, PhD3*, Eric Perkey, MD, PhD3*, Anneka Allman, BA4*, Frederick Allen, PhD5*, Joshua D Brandstadter, MD, PhD, MSc6, Burkhard Ludewig, PhD7* and Chris Siebel, PhD, BA8*

1University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA
2Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
3University of Pennsylvania, Philadelphia, PA
4Department of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA
5Perelman School of Medicine, Philadelphia, PA
6Division of Hematology and Oncology, Abramson Cancer Center University of Pennsylvania, SWARTHMORE, PA
7Institute of Immunobiology, Kantonsspital St. Gallen, St Gallen, Switzerland
8Department of Oncology, Genentech Inc, South San Francisco, CA

*signifies non-member of ASH